by Valet | Feb 4, 2021 | Clinical Trial, COVID-19, Press Release
Personalized Stem Cells, Inc (PSC), a human adipose-derived stem cell company, announces that the first patients have received stem cell therapy for the treatment of COVID-19 as part of an FDA approved clinical trial. The ongoing clinical trial and stem cell platform,...
by Valet | Apr 14, 2020 | Blog, COVID-19, Stem Cell Therapy
Recently, Personalized Stem Cells (PSC) was asked by the White House Task Force to apply to the FDA for expedited review of their application for using stem cells to treat patients with COVID-19. Stem cell therapy is a distinct approach that treats lung inflammation...
